Molecular Targets for Thyroid Cancer Therapies
The incidence of thyroid cancer has been increasing over the past decade, likely due to increased detection of subclinical disease. In recent years, a growing number of new and improved approaches to the overall management of advanced thyroid cancers have been developed. Dr. Marcia Brose discusses the molecular pathways that have resulted in the identification of essential biologic targets within the tumor and its microenvironment, and reviews the mechanisms of novel targeted agents for the treatment of advanced disease that has created a positive outlook for the future of thyroid cancer treatment.
Earn accreditation for this activity here:
© 2013 Imedex, LLC.